GALVUS MET Trademark

Trademark Overview

On Wednesday, March 25, 2009, a trademark application was filed for GALVUS MET with the United States Patent and Trademark Office. The USPTO has given the GALVUS MET trademark a serial number of 77698482. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 13, 2013. This trademark is owned by Novartis AG. The GALVUS MET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of and treatment of ocular disorders or diseases; bacteria-based diseases and for the treatment of diabetes; anti-infective preparations, antiviral preparations, antifungal preparations and antibiotics
galvus met

General Information

Serial Number77698482
Word MarkGALVUS MET
Filing DateWednesday, March 25, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 13, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 19, 2010

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"MET"
Description of MarkThe mark consists of the words "GALVUS MET" under two lines and a sphere; the color gray is intended to show shading or contrast only.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of and treatment of ocular disorders or diseases; bacteria-based diseases and for the treatment of diabetes; anti-infective preparations, antiviral preparations, antifungal preparations and antibiotics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 30, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 13, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 13, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 16, 2012EXTENSION 5 GRANTED
Friday, October 12, 2012EXTENSION 5 FILED
Friday, October 12, 2012TEAS EXTENSION RECEIVED
Saturday, April 7, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2012EXTENSION 4 GRANTED
Wednesday, April 4, 2012EXTENSION 4 FILED
Wednesday, April 4, 2012TEAS EXTENSION RECEIVED
Friday, September 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2011EXTENSION 3 GRANTED
Tuesday, September 20, 2011EXTENSION 3 FILED
Tuesday, September 20, 2011TEAS EXTENSION RECEIVED
Friday, April 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2011EXTENSION 2 GRANTED
Monday, April 11, 2011EXTENSION 2 FILED
Thursday, April 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 11, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 11, 2010EXTENSION 1 GRANTED
Monday, October 11, 2010EXTENSION 1 FILED
Monday, October 11, 2010TEAS EXTENSION RECEIVED
Tuesday, April 13, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 19, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2010PUBLISHED FOR OPPOSITION
Monday, December 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, December 14, 2009ASSIGNED TO LIE
Monday, November 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 25, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 25, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 25, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2009NON-FINAL ACTION E-MAILED
Wednesday, June 3, 2009NON-FINAL ACTION WRITTEN
Thursday, May 28, 2009ASSIGNED TO EXAMINER
Tuesday, March 31, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, March 30, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 28, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

galvus system preparations disorders treatment prevention diseases pharmaceutical ocular transplantation bacteria